4-chloro-7-nitrobenzofurazan has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, O; Buschiazzo, A; Cossu, V; De Flora, A; Emionite, L; Ferrando, S; Guida, L; Magnone, M; Marini, C; Orengo, AM; Sambuceti, G; Spinelli, S; Sturla, L; Vigliarolo, T; Zocchi, E | 1 |
| Ishida, Y; Janprasit, J; Matsuoka, Y; Morales, NP; Okamoto, Y; Tada, A; Yamada, KI; Yamato, M | 1 |
| Dewhirst, MW; Fontanella, AN; Frees, AE; Hansen, K; Rajaram, N; Ramanujam, N; Zhong, J | 1 |
| Hakamada, K; Kijima, H; Sasaki, A; Yamada, K; Yokoyama, H; Yoshizawa, T | 1 |
| Hardikar, MR; Joshi, BN; Kulkarni, AA; Kulkarni, PP; Varma, ME | 1 |
| Ariyoshi, M; Enoki, M; Fujiki, A; Ide, S; Ishida, Y; Kusakabe, D; Matsuoka, Y; Mito, F; Shikimachi, K; Tada, A; Yamada, K; Yamasaki, T; Yamato, M | 1 |
| Bu, L; Chang, X; Cheng, X; Qu, S; Sheng, C; Su, B; Yao, Q | 1 |
| Xie, W; Yu, Y; Zhao, Y | 1 |
| Ando, T; Goto, H; Ishiguro, K; Maeda, O; Watanabe, O | 1 |
| Abeti, R; Abramov, AY; Duchen, MR | 1 |
| Bederman, IR; Burgess, JD; Jiang, D; Kelley, TJ; Previs, SF; White, NM | 1 |
| Furuya, K; Ginis, I; Hallenbeck, JM; Klimanis, D; Ruetzler, C; Spatz, M; Zimmermann, C | 1 |
12 other study(ies) available for 4-chloro-7-nitrobenzofurazan and Disease Models, Animal
| Article | Year |
|---|---|
Insulin-independent stimulation of skeletal muscle glucose uptake by low-dose abscisic acid via AMPK activation.
Topics: 4-Chloro-7-nitrobenzofurazan; Abscisic Acid; AMP-Activated Protein Kinase Kinases; Animals; Cell Line; Deoxyglucose; Diabetes Mellitus; Disease Models, Animal; Glucose; Insulin; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Myoblasts; Protein Kinases; Rats; Rats, Wistar; RNA, Small Interfering; TRPM Cation Channels | 2020 |
Detection and inhibition of lipid-derived radicals in low-density lipoprotein.
Topics: 4-Chloro-7-nitrobenzofurazan; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Chromans; Cyclic N-Oxides; Deferoxamine; Disease Models, Animal; Fluorescent Dyes; Free Radicals; Humans; Iron; Iron Overload; Lipid Peroxidation; Lipoproteins, LDL; Liver; Male; Mice; Mice, Inbred ICR; Oxidative Stress; Spectrometry, Fluorescence | 2017 |
Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Breast Neoplasms; Cell Line, Tumor; Deoxyglucose; Disease Models, Animal; Female; Fluorescent Dyes; Hypoxia; Kinetics; Mice; Neoplasm Metastasis; Oxygen Consumption; Regional Blood Flow; Sulfur Dioxide; Time Factors | 2013 |
Imaging hamster model of bile duct cancer in vivo using fluorescent L-glucose derivatives.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Bile Duct Neoplasms; Bile Ducts; Cholangiocarcinoma; Cricetinae; Deoxyglucose; Disease Models, Animal; Endoscopes; Female; Fluorescence; Mesocricetus; Microscopy, Confocal | 2016 |
Elucidation of hypoglycemic action and toxicity studies of insulin-like protein from Costus igneus.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Blood Glucose; Costus; Deoxyglucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Mice; Muscle, Skeletal; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Necrosis Factor-alpha | 2016 |
Fluorescence probes to detect lipid-derived radicals.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Apoptosis; Cell Line, Tumor; Cyclic N-Oxides; Diethylnitrosamine; Disease Models, Animal; Fluorescent Dyes; Free Radical Scavengers; Free Radicals; Inflammation; Lipid Peroxidation; Lipids; Liver Neoplasms; Molecular Structure; Oxidative Stress; Rats; Spectrometry, Fluorescence | 2016 |
Activated central galanin type 1 receptor alleviated insulin resistance in diabetic rat muscle.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Blood Glucose; Body Weight; Bradykinin; Deoxyglucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Galanin; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Peptide Fragments; PPAR gamma; Rats; Rats, Wistar; Receptor, Galanin, Type 1; Subcellular Fractions; Vesicle-Associated Membrane Protein 2 | 2016 |
[Effect of Chaihu Shugan Tang on excitability in different brain regions of pentylenetetrazole-kindled chronic epileptic rats].
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Aspartic Acid; Brain; Chronic Disease; Deoxyglucose; Disease Models, Animal; Drugs, Chinese Herbal; Epilepsy; Glutamic Acid; Hippocampus; Humans; Kindling, Neurologic; Male; Pentylenetetrazole; Random Allocation; Rats; Valproic Acid | 2010 |
Novel mouse model of colitis characterized by hapten-protein visualization.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Colitis; Colon; Cytokines; Disease Models, Animal; Endocytosis; Female; Haptens; Intestinal Mucosa; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Protein Binding; Proteins; Skin Tests | 2010 |
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Topics: 4-Chloro-7-nitrobenzofurazan; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Calcium; Cell Death; Coculture Techniques; Deoxyglucose; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; NAD; NADPH Oxidases; Neurons; Oxygen Consumption; Peptide Fragments; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate | 2011 |
Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Biological Transport; Cell Membrane; Cells, Cultured; Cholesterol; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Docosahexaenoic Acids; Enzyme Inhibitors; Epithelial Cells; Homeostasis; Humans; Interleukin-6; Interleukin-8; Lysosomal Storage Diseases; Mice; Microelectrodes; Nitric Oxide Synthase Type II; Smad3 Protein | 2007 |
Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Blood-Brain Barrier; Body Temperature; Body Weight; Brain; Brain Ischemia; Ceramides; Cerebrovascular Circulation; Disease Models, Animal; Fluorescent Dyes; Interleukin-6; Ischemic Preconditioning; Leukocytes; Lipopolysaccharides; Neuroprotective Agents; Rats; Rats, Inbred SHR; Signal Transduction; Tumor Necrosis Factor-alpha | 2001 |